We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Oral Bacteria May Cause Preterm Births

By Biotechdaily staff writers
Posted on 24 Apr 2006
Using new DNA fingerprinting technology to find bacteria that cannot be cultured and grown in a laboratory, researchers have discovered oral bacteria in the amniotic fluid of a woman in preterm labor. More...


Lead researcher Dr. Yiping Han, a microbiologist in the department of biological sciences at the Case Western Reserve University School of Dental Medicine (Cleveland, OH, USA), has spent about three years searching for this link.

Dr. Han and colleagues found the link during a pilot study of 34 women undergoing amniocentesis. Six of the women delivered before 30 weeks and had a higher risk for possible infections. Only one woman was found to have an infection. Tests of the amniotic fluid revealed the presence of Bergeyella bacteria, one of 700 bacteria found in the mouth. Since it could not be grown in culture, this bacterium could not be studied until new techniques such as polymerase chain reaction (PCR) became available to track the DNA of bacteria. The study continues Dr. Han's research into the suspicion that oral bacteria, once entering the blood, can cause a host of health problems, including preterm labor.

Finding how the bacteria got into the amniotic fluid might suggest a method of prevention. It is known that women can contract a uterine infection vaginally while pregnant. A pathway of infection has been suspected through the mouth in pregnant women with periodontal disease, where the oral bacteria enter the blood through bleeding gums. However, the woman with the infection showed no signs of post-partum periodontal disease. The study results were reported in the April 2006 issue of the Journal of Clinical Microbiology.

"If periodontal disease is not present, then this raises more questions about how the bacteria got into the amniotic fluid,” observed Dr. Han.



Related Links:
Case Western Reserve U.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.